Pharmaceutical

Image

Global Mineral and Bone Disorder Treatment Market – Industry Trends and Forecast to 2030

  • Pharmaceutical
  • Upcoming Report
  • Nov 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Mineral and Bone Disorder Treatment Market – Industry Trends and Forecast to 2030

Market Size in USD Billion

CAGR - % Diagram

Diagram Forecast Period 2022–2030
Diagram Market Size (Base Year) USD 3.02 Billion
Diagram Market Size (Forecast Year) USD 5.00 Billion
Diagram CAGR %

Global Mineral And Bone Disorder Treatment Market, By Type (Biphosphates, Estrogens, Phosphate Binders, Non-Calcium, Non-Metal Based Binders and Magnesium Based Binders), Treatment (Diet, Nutrition, Medication, Supplements and Dialysis), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) – Industry Trends and Forecast to 2030.

Mineral And Bone Disorder Treatment Market Analysis and Size

The mineral and bone disorder treatment market is forecasted to secure a rising growth with the increasing incidence of metabolic disorders and chronic kidney diseases (CDKs). It is estimated that most people above 50 years are suffering from osteoporosis while a closer count of the people could be at the risk of developing the bone disease. Global bone and mineral metabolism disorders treatment market is continue to witness positive growth due to the increased frequency of Chronic Kidney Diseases (CKD) and metabolic diseases. According to National Kidney Foundation (NKF), CKD in US was 13.5% in 2010.

Data Bridge Market Research analyses a growth rate in the mineral and bone disorder treatment market in the forecast period 2023-2030. The expected CAGR of mineral and bone disorder treatment market is tend to be around 6.50% in the mentioned forecast period. The market was valued at USD 3.02 billion in 2022, and it would grow up to USD 5 billion by 2030. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Mineral And Bone Disorder Treatment Market Scope and Segmentation

Report Metric

Details

Forecast Period

2023 to 2030

Base Year

2022

Historic Years

2021 (Customizable to 2015 - 2020)

Quantitative Units

Revenue in USD Billion, Volumes in Units, Pricing in USD

Segments Covered

Type (Biphosphates, Estrogens, Phosphate Binders, Non-Calcium, Non-Metal Based Binders and Magnesium Based Binders), Treatment (Diet, Nutrition, Medication, Supplements and Dialysis), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Market Players Covered

Pfizer Inc (U.S.), Mylan N.V. (U.S.), Novartis AG (Switzerland), Hikma Pharmaceuticals plc (U.K.), Aurobindo Pharma (India), Melinta Therapeutics, Inc (U.S.), Bristol-Myers Squibb Company (U.S.), GSK plc. (U.K.), Bayer AG (Germany), Teva Pharmaceuticals Industries Ltd. (Israel), Lilly (U.S.), AstraZeneca (U.K.), Lilly (U.S.), Amgen Inc. (U.S.)

Market Opportunities

  • Increased Elderly Population
  • Increasing Demand for Retail Pharmacies

Market Definition

Mineral and bone is a disorder which is characterized by abnormal hormone levels and kidney failure. This causes improper functioning of vitamin D metabolism and leads to abnormalities in calcium, phosphorous and parathyroid hormone levels. Metal and bone disorders also includes calcifications of vascular and other soft tissues in kidney. Thus, the miner and bone disorders can cause serious chronic kidney diseases, if left untreated. Common symptoms include bone pain, heart problems,  itchy skin, blocked blood vessels , nerve problems, anaemia and difficulty fighting against germs.

Global Mineral And Bone Disorder Treatment Market Dynamics

Drivers

  • Increased Incidence of Osteoporosis

Growing incidence of osteoporosis are projected to boost the market growth during the forecast period 2023-2030. For instance, as per the National Osteoporosis Foundation (NOF) records, around 54 million people in America have osteoporosis. The increase in the osteoporosis disease pose a huge demand for the osteoporosis drugs. Thus, it boosts the market growth.

  • Higher Drug Approvals By Several Market Players

More and more drug approvals lead to the increase in th market growth. For instance, in 2010, the FDA approved a monoclonal antibody named Denosumab for treating patients suffering from postmenopausal women at high risk of fractures. Additionally, Teriparatide is a synthetic parathyroid hormone form and the only FDA-approved anabolic. Phosphate binding agents and dialysis are also used in the treatment of hyperphosphatemia. This boost the market growth.

Opportunities

  • Increased Elderly Population

Increasing number of elderly populations are suffering from osteoporosis disease. There is very huge growth in osteoporosis disease in geriatric population. For instance, according to The National Osteoporosis Foundation (NOF) reports, around one out of two women and one out of four men aged 50 and above is suffering from a bone break because of osteoporosis and other bone related disorder. This creates opportunity for the market expansion.

  • Increasing Demand for Retail Pharmacies

The rise in the number of mineral and bone disorder treatment delivered through retail pharmacies and the increase in the number of retail pharmacies in highly developed countries create opportunities for the market growth. Additionally, patients prefer retail pharmacies for purchasing drugs, as these are easily available.

 Restraints/Challenges

  • Risk of Side-Effects

The varied side-effects that are associated with mineral and bone disorder treatment could restrain the growth of the global mineral and bone disorder treatment market over a forecast period. Side-effects such as dyspepsia and headache, and to a lesser extent, myalgia, low-back pain, flushing, and rhinitis are visible with the use of mineral and bone disorder treatment.

  • High Cost

The huge expenditure associated with these agents hamper the market growth. Several surgeries, medications are hampering the growth of the market.

This mineral and bone disorder treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the mineral and bone disorder treatment contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Mineral And Bone Disorder Treatment Market Scope

The mineral and bone disorder treatment market is segmented on the basis of type, treatment, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

  • Biphosphates
  • Estrogens
  • Phosphate Binders
  • Non-Calcium
  • Non-Metal Based Binders
  • Magnesium Based Binders

Treatment

  • Diet
  • Nutrition
  • Medication
  • Supplements
  • Dialysis

End User

  • Hospitals
  • Homecare
  • Specialty Clinics
  • Others

Distribution Channel

  • Hospital Pharmacy
  • Online Pharmacy
  • Retail Pharmacy

Mineral And Bone Disorder Treatment Market Regional Analysis/Insights

The mineral and bone disorder treatment market is analyzed and market size insights and trends are provided by type, treatment, distribution channel and end-user as referenced above.

The major countries covered in the mineral and bone disorder treatment market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Asia-Pacific has been witnessing positive growth for mineral and bone disorder treatment market throughout the forecasted period due to increased new research and developments on mineral and bone disorder treatment

North America dominates the market due to the presence of key manufacturers of the product is high and, increasing research and development activities.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Global Mineral And Bone Disorder Treatment Market Share Analysis

The mineral and bone disorder treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to mineral and bone disorder treatment market

Key players operating in the mineral and bone disorder treatment market include:

  • Pfizer Inc (U.S.)
  • Mylan N.V. (U.S.)
  • Novartis AG (Switzerland.)
  • Hikma Pharmaceuticals plc (U.K.)
  • Aurobindo Pharma (India)
  • Melinta Therapeutics, Inc (U.S.)
  • Bristol-Myers Squibb Company (U.S.)
  • GSK plc. (U.K.)
  • Bayer AG (Germany)
  • Teva Pharmaceuticals Industries Ltd. (Israel)
  • Lilly (U.S.)
  • Amgen Inc. (U.S.)


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

FREQUENTLY ASK QUESTIONS

The Mineral and Bone Disorder Treatment Market is projected to grow at a CAGR of 6.50% during the forecast period by 2030.
The future market value of the Mineral and Bone Disorder Treatment Market is expected to reach USD 5 billion by 2030.
The major players in the Mineral and Bone Disorder Treatment Market are Pfizer Inc (U.S.), Mylan N.V. (U.S.), Novartis AG (Switzerland), Hikma Pharmaceuticals plc (U.K.), Aurobindo Pharma (India), Melinta Therapeutics, Inc (U.S.), Bristol-Myers Squibb Company (U.S.), etc.
The countries covered in the Mineral and Bone Disorder Treatment Market are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, etc.
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials